1. Home
  2. DAIO vs ITRM Comparison

DAIO vs ITRM Comparison

Compare DAIO & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$3.06

Market Cap

22.3M

Sector

Industrials

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
ITRM
Founded
1969
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
24.3M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
DAIO
ITRM
Price
$3.06
$0.03
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.22
$9.00
AVG Volume (30 Days)
45.5K
30.9M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.43
EPS
N/A
N/A
Revenue
$21,500,000.00
N/A
Revenue This Year
$4.51
N/A
Revenue Next Year
$30.29
$947.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$0.03
52 Week High
$3.49
$1.16

Technical Indicators

Market Signals
Indicator
DAIO
ITRM
Relative Strength Index (RSI) 65.46 26.10
Support Level $2.98 N/A
Resistance Level $3.32 $0.39
Average True Range (ATR) 0.22 0.02
MACD 0.03 -0.01
Stochastic Oscillator 81.08 3.34

Price Performance

Historical Comparison
DAIO
ITRM

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: